María del Val
Toledo Lobo
Profesor/a Contratado/a Doctor/a
Hospital Universitario de la Princesa
Madrid, EspañaPublicacions en col·laboració amb investigadors/es de Hospital Universitario de la Princesa (4)
2022
-
Evaluation of AIF-1 (Allograft Inflammatory Factor-1) as a Biomarker of Crohn’s Disease Severity
Biomedicines, Vol. 10, Núm. 3
2017
-
Infliximab therapy reverses the increase of allograft inflammatory factor-1 in serum and colonic mucosa of rats with inflammatory bowel disease
Biomarkers, Vol. 22, Núm. 2, pp. 133-144
2014
-
Effect of Infliximab in oxidised serum albumin levels during experimental colitis
Biomarkers, Vol. 19, Núm. 8, pp. 693-701
2013
-
Azathioprine desensitizes liver cancer cells to insulin-like growth factor 1 and causes apoptosis when it is combined with bafilomycin A1
Toxicology and Applied Pharmacology, Vol. 272, Núm. 3, pp. 568-578